Clinical Trials Directory

Trials / Completed

CompletedNCT01834482

Modified Atkins Diet Plus KetoCal for Adult Epilepsy

A Randomized, Open-label Evaluation of KetoCal® in Initial Combination With the Modified Atkins Diet for the Dietary Management of Intractable Adult Epilepsy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The modified Atkins diet (MAD) has been shown to be effective in treating children and adults with medically resistant seizures. A recent study in children showed that the use of KetoCal® once per day in addition to the MAD appeared to be beneficial when used during the first month. The investigators hypothesize that including a daily KetoCal® liquid tetrapak with one meal during the initial month of the MAD will produce urinary ketosis in more adult patients than the MAD alone and will lead to greater seizure reduction.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTModified Atkins dietPatients will receive the modified Atkins diet with a 20 gram per day carbohydrate limit and encouragement to consume plenty of fat and eat to satiety.
DIETARY_SUPPLEMENTKetoCalPatients will receive a KetoCal 4:1 ratio (fat: carbohydrates and protein) liquid daily for the first month (if randomized to this arm of the study). They will also be started on the modified Atkins diet.

Timeline

Start date
2013-03-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2013-04-18
Last updated
2018-08-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01834482. Inclusion in this directory is not an endorsement.

Modified Atkins Diet Plus KetoCal for Adult Epilepsy (NCT01834482) · Clinical Trials Directory